Aclaris Therapeutics Inc (ACRS)
1.175
-0.04
(-3.69%)
USD |
NASDAQ |
May 10, 16:00
1.175
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Gross Profit (Quarterly): 11.14M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 11.14M |
September 30, 2023 | 1.09M |
June 30, 2023 | 0.277M |
March 31, 2023 | 0.659M |
December 31, 2022 | 6.239M |
September 30, 2022 | 10.80M |
June 30, 2022 | 0.46M |
March 31, 2022 | 0.298M |
December 31, 2021 | 0.352M |
September 30, 2021 | 0.56M |
June 30, 2021 | 0.561M |
March 31, 2021 | 0.575M |
December 31, 2020 | 0.294M |
September 30, 2020 | 0.26M |
June 30, 2020 | 0.657M |
Date | Value |
---|---|
March 31, 2020 | 0.138M |
December 31, 2019 | 0.068M |
September 30, 2019 | 0.157M |
June 30, 2019 | -0.108M |
March 31, 2019 | 0.056M |
December 31, 2018 | 0.506M |
September 30, 2018 | 0.051M |
June 30, 2018 | 2.495M |
March 31, 2018 | 0.151M |
December 31, 2017 | 0.245M |
September 30, 2017 | 0.231M |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-0.108M
Minimum
Jun 2019
11.14M
Maximum
Dec 2023
1.814M
Average
0.46M
Median
Jun 2022
Gross Profit (Quarterly) Benchmarks
Aldeyra Therapeutics Inc | -- |
Akoya Biosciences Inc | 16.62M |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.053M |
IGC Pharma Inc | 0.133M |